Sort   by:  
 Page size 
UnknownGenetic Engineering of Natural Killer Cells for Enhanced Antitumor Function.
Not available
S-EPMC7772419 | biostudies-literature
UnknownQualification of a flow cytometry-based method for the evaluation of in vitro cytotoxicity of GTA002 natural killer cell therapy.
Not available
S-EPMC10830575 | biostudies-literature
UnknownAdoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma.
Not available
S-EPMC8471577 | biostudies-literature
UnknownIL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Not available
S-EPMC3909052 | biostudies-literature
UnknownThe Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.
Not available
S-EPMC5450018 | biostudies-literature
UnknownDefining early human NK cell developmental stages in primary and secondary lymphoid tissues.
Not available
S-EPMC3272048 | biostudies-literature
UnknownCombined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.
Not available
S-EPMC4485802 | biostudies-literature
UnknownEx vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.
Not available
S-EPMC3475144 | biostudies-literature
UnknownCombination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
Not available
S-EPMC4912059 | biostudies-literature
UnknownNatural killer cells in clinical development as non-engineered, engineered, and combination therapies.
Not available
S-EPMC9644572 | biostudies-literature
Sort   by:  
 Page size